Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy

Hip Injuries Clinical Trial

Official title:

Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01907191
• Other study ID #: 13-06-001
• Status: Terminated
• Phase: N/A
• Start date: July 2013
• Est. completion date: January 30, 2019

Study information

• Verified date: August 2022
• Source: Saint Francis Care
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours

Description:

Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good pain control encourages early participation in rehabilitation program, increases success of the surgery, and improves patient satisfaction. Typically, postoperative analgesia is provided to these patients either with nerve blocks or opioid medications. Both these methods provide good pain relief but nerve blocks are associated with weakness of lower extremity muscles which interferes with early ambulation and increase the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus, urinary retention, sedation and respiratory depression.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 23
• Est. completion date: January 30, 2019
• Est. primary completion date: January 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients having hip arthroscopy

Exclusion Criteria:

• History of neurologic disease, neuropathy, diabetes

• Allergy to local anesthetic solution

• Chronic use of narcotics

• Inability to give consent/cooperate with study

• History of previous hip arthroscopy on the ipsilateral side

• Pregnancy

Related Conditions & MeSH terms

• Hip Injuries

Intervention

Drug:
• liposomal bupivacaine
(Ultrasound guided injection of liposomal bupivacaine) for patients undergoing hip arthroscopy
• Bupivacaine
(around the anterior, lateral and medial aspect of hip joint) for patients undergoing hip arthroscopy

Locations

Country	Name	City	State
United States	Saint Francis Hospital and Medical Center	Hartford	Connecticut

Sponsors (1)

Lead Sponsor	Collaborator
Saint Francis Care

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Number of Patients Reporting Sleep Disturbance	Analysis of sleep disturbance during hospital stay (participants who reported being woken up by pain on post operative days 1, 2 & 3)	Post Operative Day 1, 2 & 3
Other	Satisfaction With Pain Management	Analysis of satisfaction with pain management during hospital stay measured on a 15 point scale (1 being extremely unsatisfied to 15 being extremely satisfied)	Post Operative Day 1, 2 & 3
Primary	Opioid Consumption (Mean Number of 5mg Oxycontin Tablets Consumed)	Consumption of 5mg Oxycontin tablets will be assessed on Post Operative Days 1, 2 & 3.	Post Operative Day 1, 2 & 3
Secondary	Pain Scores	Analysis of pain scores (at rest and ambulation) during hospital stay. Measured on a 10 point pain scale (1 being no pain and 10 being worst pain imaginable)	Post Operative Day 1, 2 & 3